pharma
Gilead’s remdesivir and three other repurposed drugs have no impact on COVID-19 mortality, WHO study finds
October 16, 2020Medical Communications, Research and Development COVID-19, pharma, remdesivir
Gilead’s antiviral therapy remdesivir has emerged as one of the most promising drugs to treat COVID-19 infections, but recent studies …
British man suffers from permanent hearing damage after contracting COVID-19
October 14, 2020Research and Development COVID-19, pharma
A 45-year-old man in the UK has been left with permanent hearing damage after being infected with the novel coronavirus, …
Johnson & Johnson to contribute a further $1 billion to US opioid settlement
October 14, 2020Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma
Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …
J&J halts COVID-19 vaccine study following unidentified participant illness
October 13, 2020Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma
Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
Takeda and Arrowhead Pharma join forces in $1m rare liver disease drug development pact
October 9, 2020Medical Communications, Research and Development Arrowhead, Takeda, pharma
A new partnership has been struck between Takeda and Arrowhead Pharmaceuticals, with both companies coming together to co-develop and license …
Amgen and Cytokinetics’ drug falls short in heart failure despite hitting primary goal
October 9, 2020Medical Communications Amgen, cytokines, heart failure, pharma
New Phase 3 data has come to light on Amgen and Cytokinetics’ cardiac myosin activator therapy omecamtiv mecarbil fell short …
Alivio Therapeutics receives $3.3m from US Department of Defense to support development of IBD drug candidate
October 5, 2020Research and Development, Sales and Marketing Alivio, US, ibd, pharma
The US Department of Defense (DoD) has committed a Technology/Therapeutic Development Award to the value of $3.3 million to biotech …
ViiV’s two-drug regimen proves non-inferior in treatment-naive HIV-1
October 5, 2020Research and Development, Sales and Marketing HIV-1, ViiV Healthcare, pharma
ViiV Healthcare has taken the opportunity at the HIV Glasgow 2020 Virtual Congress to unveil three-year Phase 3 data from …
Remdesivir has a “favourable” benefit/risk profile in COVID-19 but more data needed, DSRU review argues
October 5, 2020Research and Development, Sales and Marketing COVID-19, Drug Safety Research Unit, pharma, remdesivir
Southampton’s Drug Safety Research Unit (DSRU) has released a systematic benefit/risk analysis of Gilead’s antiviral drug remdesivir in the treatment …
Covis Group to acquire AMAG Pharmaceuticals in $647m deal
October 5, 2020Sales and Marketing AMAG Pharmaceuticals, Covis group, acquisition, pharma
Luxembourg-based Covis Group is set to acquire Massachusetts-based AMAG Pharmaceuticals in a new deal worth approximately $647 million on an …
Pharmafile.com’s weekly COVID-19 news round-up
September 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten
The coronavirus news this week focuses on the development of treatments to alleviate symptoms of the virus, as Australian biotech …
The October 2020 issue of Pharmafocus is available to read free online now!
September 29, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, October 2020, Pharmafocus, digital edition, pharma
The latest monthly edition of Pharmafocus is available to read for free online now! As the US sails past the …
Jyseleca secures European approval in rheumatoid arthritis
September 28, 2020Research and Development, Sales and Marketing Europe, Jyseleca, arthritis, pharma
The European Commission has awarded approval to Gilead and Galpagos for their oral JAK inhibitor Jyseleca (filgotinib) as a treatment …
AstraZeneca and Samsung Biologics partner up in $330m manufacturing and supply deal
September 22, 2020Manufacturing and Production AstraZeneca, Samsung BioLogics, manufacturing, pharma
AstraZeneca has announced a new global manufacturing and supply partnership with Samsung Biologics, said to be worth a potential $330.8 …
Positive five-year Keytruda survival data revealed at ESMO in metastatic, PD-L1+ non-small cell lung cancer
September 22, 2020Manufacturing and Production, Research and Development ESMO 2020, MSD, keytruda, pharma
MSD took the opportunity at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 to unveil new Phase 3 …
